Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT02793128What this trial is testingThe OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC StudyWho this might be right forCarcinoma, Transitional CellTransitional Cell Carcinoma of Renal Pelvis UroGen Pharma Ltd. 71
Testing effectiveness (Phase 2)Study completedNCT00006111What this trial is testingSurgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer UNICANCER 53
Testing effectiveness (Phase 2)UnknownNCT00005958What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Amgen
Not applicableLooking for participantsNCT01050504What this trial is testingCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerWho this might be right forLocalized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more University of Washington 1,500
Testing effectiveness (Phase 2)Ended earlyNCT04228042What this trial is testingInfigratinib Before Surgery for the Treatment of Upper Tract Urothelial CancerWho this might be right forRenal Pelvis and Ureter Urothelial Carcinoma M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT06598761What this trial is testingPostoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCWho this might be right forUreter CancerRenal Pelvic CarcinomaAdvanced Urothelial Carcinoma Peking University First Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591805What this trial is testingHERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUCWho this might be right forUpper Urinary Tract Urothelial Carcinoma RenJi Hospital 49
Testing effectiveness (Phase 2)Looking for participantsNCT06823427What this trial is testing9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forUrothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma Recurrent+1 more Mabwell (Shanghai) Bioscience Co., Ltd. 60
Not applicableStudy completedNCT06941038What this trial is testingIntraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial CarcinomaWho this might be right forBladder Cancer RecurrenceIntravesical InstillationUpper Urinary Tract Carcinoma Ankara Etlik City Hospital 270
Early research (Phase 1)Study completedNCT00082719What this trial is testingShort-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumWho this might be right forBladder CancerUrethral Cancer M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT00623064What this trial is testingLapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter European Organisation for Research and Treatment of Cancer - EORTC 18
Testing effectiveness (Phase 2)Study completedNCT00471536What this trial is testingPazopanib in Treating Patients With Metastatic Urothelial CancerWho this might be right forDistal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+5 more National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 677
Testing effectiveness (Phase 2)Looking for participantsNCT07667335What this trial is testingEnfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial CancerWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+10 more Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104What this trial is testingARID1A and/or KDM6A Mutation and CXCL13 ExpressionWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT01234519What this trial is testingA Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapyWho this might be right forUrothelial Carcinoma AEterna Zentaris 12
Testing effectiveness (Phase 2)Study completedNCT00066352What this trial is testingBortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or UreterWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter University Health Network, Toronto